| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | CA2415438C .alpha. crystalline form of perindopril tert-butylamine salt |
| 01/20/2009 | CA2372836C Substituted pyrrolidines as cell adhesion inhibitors |
| 01/20/2009 | CA2236263C Methods for use of mpl ligands with primitive human stem cells |
| 01/15/2009 | WO2009007661A2 Use of a chromatography substrate for reducing the amount of adamts13 in a solution derived from plasma |
| 01/15/2009 | WO2009007457A2 Compounds and methods for modulating rho gtpases |
| 01/15/2009 | WO2009007112A2 Thrombomodulin for increasing reperfusion and preventing blood vessels obstruction |
| 01/15/2009 | WO2009007029A1 Imidazo-, pyrazolopyrazines and imidazotriazines and their use |
| 01/15/2009 | WO2009007028A1 Prodrug derivatives of 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine-3-carboxamide |
| 01/15/2009 | WO2009007027A1 Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorders |
| 01/15/2009 | WO2009007026A1 Aminoacyl prodrugs |
| 01/15/2009 | WO2009007015A1 Malonamide derivatives with antithrombotic activity |
| 01/15/2009 | WO2008079836A3 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 01/15/2009 | US20090018193 Essential fatty acids in the prevention of cardiovascular events |
| 01/15/2009 | US20090018189 Hormone Sensitive Lipase Modulators And Methods Of Use |
| 01/15/2009 | US20090018183 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/15/2009 | US20090018136 Methods and compositions for the treatment of vascular disease |
| 01/15/2009 | US20090018082 Use of Factor VIIa or Factor VIIa Equivalents for Treating Trauma |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018069 Methods and Compositions Related to Mutant Kunitz Domain I of Tfpi-2 |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090017559 Methods for diagnosing renal disorders |
| 01/15/2009 | US20090017146 Beta Vulgaris-Based Products |
| 01/15/2009 | US20090017137 Methods and compositions for the prevention and treatment of anemia |
| 01/15/2009 | US20090017017 Anti-rhesus d recombinant polyclonal antibody and methods of manufacture |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | US20090017007 Liquid factor vii composition |
| 01/15/2009 | US20090016965 Internal image antibodies for optical imaging and therapy |
| 01/15/2009 | DE4407386B4 Verfahren zur Reaktivierung von gereinigten Membranproteinen durch Einfrieren A process for reactivating purified membrane proteins by freezing |
| 01/15/2009 | DE102007032349A1 Imidazo-, Pyrazolopyrazine und Imidazotriazine und ihre Verwendung Imidazo, Pyrazolopyrazine and imidazotriazines and their use |
| 01/15/2009 | DE102007032347A1 Aminoacyl-Prodrugs Aminoacyl prodrugs |
| 01/15/2009 | DE102007032345A1 Aminoacyl-Prodrugs Aminoacyl prodrugs |
| 01/15/2009 | DE102007032344A1 Prodrug-Derivate von Prodrug derivatives of 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3-carboxamid |
| 01/15/2009 | CA2693603A1 Aminoacyl prodrugs |
| 01/15/2009 | CA2693507A1 Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorders |
| 01/15/2009 | CA2693396A1 Malonamide derivatives with antithrombotic activity |
| 01/15/2009 | CA2692485A1 Compounds and methods for modulating rho gtpases |
| 01/15/2009 | CA2691604A1 Use of a chromatography substrate for reducing the amount of adamts13 in a solution derived from plasma |
| 01/14/2009 | EP2014776A2 Diagnosis of diseases associated with DNA transcription |
| 01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
| 01/14/2009 | EP2014652A1 Activating agent for peroxisome proliferator activated receptor |
| 01/14/2009 | EP2014651A1 Compounds and methods for modulating Rho GTPases |
| 01/14/2009 | EP2014299A1 Subcutaneous administration of coagulation factor VII |
| 01/14/2009 | EP2014296A1 Novel strategies for increasing the reperfusion in obstructed blood vessel |
| 01/14/2009 | EP2013621A1 ANTI-FACTOR XIIa THERAPY |
| 01/14/2009 | EP2013184A1 Sulfonamide compounds useful as edg receptor modulators |
| 01/14/2009 | EP2013177A1 Dicarboxamide derivatives |
| 01/14/2009 | EP2012828A2 Compositions and methods for the treatment of cardiovascular disease |
| 01/14/2009 | EP2012770A2 Trivalent chromium compounds, compositions and methods of use |
| 01/14/2009 | EP1844050B1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 01/14/2009 | EP1451151B1 Hydroperylene derivatives |
| 01/14/2009 | EP1331221B1 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 01/14/2009 | EP1283057B1 Cell proliferation inhibitors |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | EP0948539B1 Peptides and compounds that bind to a receptor |
| 01/14/2009 | CN101346471A Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer |
| 01/14/2009 | CN101346386A Process for the preparation of S-(+)-clopidogrel by optical resolution |
| 01/14/2009 | CN101346365A Agent for treatment of circulatory failure |
| 01/14/2009 | CN101343332A Method for extracting holothurian polyoses with holothurian processing waste liquor |
| 01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
| 01/14/2009 | CN101343278A Preparation method for hydrogenated pyridine derivant and its salt |
| 01/14/2009 | CN101343251A Thrombopoietin mimetics |
| 01/14/2009 | CN101343250A Thrombopoietin mimetics |
| 01/14/2009 | CN101342343A Medicament composition for treating anemia |
| 01/14/2009 | CN101342294A Chinese medicinal composition for hemostasis and scar remove, and preparation method |
| 01/14/2009 | CN101342276A Chinese medicinal herb for preventing and treating acute hydropsy of ablactated pigling and preparation method thereof |
| 01/14/2009 | CN101342270A Pure natural medicament for treating mediterranean anemia |
| 01/14/2009 | CN101342267A Donkey-hide gelatin angelica polymorpha & hoantchy particle and method of preparing the same |
| 01/14/2009 | CN101342238A Medicinal composition for treating cardiovascular and cerebrovascular diseases |
| 01/14/2009 | CN101342235A Method for preparation of í«dilution of dense blood in human body in 36 hoursí» |
| 01/14/2009 | CN101342230A Radix astragali particle and quality control method thereof |
| 01/14/2009 | CN101342189A Preparation method for externally used ophicalcitum compound emergency life saving hemostatic |
| 01/14/2009 | CN101342188A Application of bletilla striata polyoses in preparing medicament for reinforcing hematopoiesis function |
| 01/14/2009 | CN101342181A Medicament composition containing tirofiban and antithrombotic medicament active component |
| 01/14/2009 | CN101342169A Thrombopoietin mimetics |
| 01/14/2009 | CN101342168A Isopropylidene shikimic acid powder injection |
| 01/14/2009 | CN101342160A Application of ocean bromine phenol in preparing medicament for treating antithrombotic forming function |
| 01/14/2009 | CN101342152A Butylbenzene phthalein tablet and preparation method thereof |
| 01/14/2009 | CN100451013C Producing technique for extracting extract products of amentoflavone |
| 01/14/2009 | CN100450502C Active extract of lamtophlomis rotata and its preparing method and use |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
| 01/13/2009 | US7476682 N-substituted piperidine derivatives as serotonin receptor agents |
| 01/13/2009 | US7476662 Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
| 01/13/2009 | CA2287907C Novel orally active iron (iii) chelators |
| 01/13/2009 | CA2105534C Tnf ligands |
| 01/08/2009 | WO2009005045A1 Substituted dihydroisoquinoline derivative |
| 01/08/2009 | WO2009004383A2 Aza-bicyclohexane compounds useful as anticoagulants |
| 01/08/2009 | WO2009004146A2 Novel herbimycin a analogue derivatives, compositions containing same and use thereof |
| 01/08/2009 | WO2009003993A1 Piperidine derivatives useful as orexin receptor antagonists |
| 01/08/2009 | US20090012167 Omega-3 Fatty Acids and Dyslipidemic Agent for Lipid Therapy |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012136 Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonists |
| 01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | US20090012091 Oximide derivatives and their therapeutical application |
| 01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012070 Pesticidal heterocycles |